Following the biopharmaceutical industry’s recent meeting with President Donald J. Trump, PhRMA president and CEO Stephen J. Ubl joined Dan Diamond on POLITICO’s Pulse Check podcast to discuss the future of innovation in health care and the industry’s new national advertising and public affairs campaign: GOBOLDLY™. The campaign focuses on the new era of medicine, public health and ways we can evolve our private payment and reimbursement system to be as innovative as the medicines our companies produce.
Listen to the full interview here, and visit GoBoldly.com and Innovation.org to learn more about #GOBOLDLY.
Holly Campbell
Holly Campbell is former deputy vice president of public affairs at PhRMA focusing on the cost and value of medicines.
Holly Campbell
Incomplete evaluations undermine patient access to transformational medicine
You won’t fix what you don’t value: Two reasons why traditional cost-effective analyses can perpetuate health inequities
PhRMA presents research at ISPOR 2022
Innovative contracts continue to gain traction and improve quality of care
"PhRMA CEO talks White House meeting, innovation & jobs with POLITICO’s Pulse Check"
Value-Driven Health Care
GoBoldly
The Value Collaborative
PhRMA CEO talks White House meeting, innovation & jobs with POLITICO’s Pulse Check
"PhRMA CEO talks White House meeting, innovation & jobs with POLITICO’s Pulse Check"